MASSMUTUAL TRUST CO FSB/ADV - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$549
-79.1%
18
-78.3%
0.00%
Q3 2023$2,624
-70.8%
83
-50.3%
0.00%
Q3 2022$9,000
-71.0%
167
-72.4%
0.00%
-100.0%
Q2 2022$31,000
-29.5%
6040.0%0.00%
-50.0%
Q1 2022$44,000
-38.9%
604
-0.8%
0.00%
-33.3%
Q4 2021$72,000
-11.1%
609
+0.8%
0.00%0.0%
Q3 2021$81,000
-17.3%
6040.0%0.00%
-25.0%
Q2 2021$98,000
+104.2%
6040.0%0.00%
+100.0%
Q1 2021$48,000
+45.5%
6040.0%0.00%0.0%
Q4 2020$33,0006040.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders